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Abstract
Objectives To develop prediction models that better estimate the pretest
probability of coronary artery disease in low prevalence populations.
Design Retrospective pooled analysis of individual patient data.
Setting 18 hospitals in Europe and the United States.
ParticipantsPatients with stable chest pain without evidence for previous
coronary artery disease, if they were referred for computed tomography
(CT) based coronary angiography or catheter based coronary
angiography (indicated as low and high prevalence settings, respectively).
Main outcome measures Obstructive coronary artery disease (≥50%
diameter stenosis in at least one vessel found on catheter based coronary
angiography). Multiple imputation accounted for missing predictors and
outcomes, exploiting strong correlation between the two angiography
procedures. Predictive models included a basic model (age, sex,
symptoms, and setting), clinical model (basic model factors and diabetes,
hypertension, dyslipidaemia, and smoking), and extendedmodel (clinical
model factors and use of the CT based coronary calcium score). We
assessed discrimination (c statistic), calibration, and continuous net
reclassification improvement by cross validation for the four largest low
prevalence datasets separately and the smaller remaining low prevalence
datasets combined.
ResultsWe included 5677 patients (3283 men, 2394 women), of whom
1634 had obstructive coronary artery disease found on catheter based
coronary angiography. All potential predictors were significantly
associated with the presence of disease in univariable and multivariable
analyses. The clinical model improved the prediction, compared with
the basic model (cross validated c statistic improvement from 0.77 to
0.79, net reclassification improvement 35%); the coronary calcium score
in the extended model was a major predictor (0.79 to 0.88, 102%).
Calibration for low prevalence datasets was satisfactory.
ConclusionsUpdated prediction models including age, sex, symptoms,
and cardiovascular risk factors allow for accurate estimation of the pretest
probability of coronary artery disease in low prevalence populations.
Addition of coronary calcium scores to the prediction models improves
the estimates.
Introduction
In the United States, about 10.2 million people have chest pain
complaints each year,1 and more than 1.1 million diagnostic
procedures of catheter based coronary angiography are
performed on inpatients each year.2 In a recent report based on
the national cardiovascular data registry of the American College
of Cardiology,3 only 41% of patients undergoing elective
procedures of catheter based coronary angiographies are
diagnosed with obstructive coronary artery disease. The report’s
authors concluded that better risk stratification was needed,
underlined by decision analyses showing that the choice of
further diagnostic investigation in patients with chest pain
depends primarily on the pretest probability of coronary artery
disease.4-6
The American College of Cardiology/American Heart
Association,7 8 European Society of Cardiology,9 and United
Kingdom10 currently recommend using the Diamond and
Forrester model11 or the Duke clinical score12 13 to estimate the
pretest probability of coronary artery disease in patients with
chest pain. The Diamond and Forrester model tends to
overestimate the probability of coronary artery disease (defined
as ≥50% stenosis), and a revised version has recently been
published.14 The Duke clinical score12 13 estimates the probability
of coronary artery disease (≥75% stenosis) which, to our
knowledge, has not been validated in populations outside the
US. Although the American College of Cardiology/American
Heart Association and European Society of Cardiology
recommend exercise electrocardiography to select patients for
further diagnostic investigation, UK guidelines recommend
using the computed tomography (CT) based coronary calcium
score in patients with a low to intermediate pretest probability
(10-29%).
We perceived a need for an updated and stepwise approach to
estimate the probability of coronary artery disease in patients
with new onset of chest pain in a low prevalence population as
clinical information and test results become available, in
particular because implementation of the guidelines needs
calculation of the pretest probability. Therefore, we aimed to
estimate the probability of obstructive coronary artery disease
on the basis of clinical presentation and cardiovascular risk
factors, and to determine the incremental diagnostic value of
exercise electrocardiography and the coronary calcium score.
Correspondence to: M G M Hunink, Departments of Epidemiology and Radiology, Erasmus University Medical Centre, PO Box 2040, 3000 CA
Rotterdam, Netherlands m.hunink@erasmusmc.nl
Extra material supplied by the author (see http://www.bmj.com/content/344/bmj.e3485?tab=related#webextra)
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Methods
Design overview
Researchers from Europe and the US formed a consortium. An
existing database of at least 80 eligible patients was required
for participation. Participation did not involve any financial
incentives. All patients had to be enrolled in single centre
studies, and local approval from the institutional review board
for the original research objectives was required. The consortium
is part of the European network for the assessment of imaging
in medicine, which is an initiative of the European Institute of
Biomedical Imaging Research.15 One of the network’s goals
was to perform pooled analyses of existing prospectively
collected data, improving power and increasing generalisability
of results.
Participants
Patients were eligible for the analysis if they presented with
stable chest pain and were referred for catheter based or CT
based coronary angiography (≥64 slice). Patients were not
eligible if they had acute coronary syndrome or unstable chest
pain, had a history of myocardial infarction or previous
revascularisation (percutaneous coronary intervention or
coronary artery bypass graft surgery), or provided no informed
consent. For the diagnosis of coronary artery disease, catheter
based coronary angiography is regarded as the reference
standard, which is an expensive and invasive procedure with a
risk of complications. Non-invasive testing is generally
recommended to select patients whomight benefit from catheter
based coronary angiography. CT based coronary angiography
is a less invasive and less expensive test, with a high sensitivity
and specificity for the detection of coronary artery disease on
catheter based coronary angiography.16-18A negative result from
CT based coronary angiography virtually excludes the presence
of obstructive coronary artery disease, whereas a positive result
might need confirmation by the catheter based test.
Fourteen datasets consisted of consecutive patients enrolled in
a prospective study for other research objectives. Four datasets
consisted of patients retrospectively identified as eligible via
electronic radiology reporting systems. Inclusion and exclusion
criteria were evaluated by experienced doctors and missing
information was obtained from patient records (web appendix
table 1).19-21
Definitions
We collected data for age, sex, symptoms, cardiovascular risk
factors, test results, and presence of coronary artery disease.
Chest pain symptoms were classified as typical, atypical, or
non-specific. Typical chest pain was defined as all of the
following criteria: (1) substernal chest pain or discomfort that
is (2) provoked by exertion or emotional stress and (3) relieved
by rest or nitroglycerine (or both). We defined atypical chest
pain as two of these criteria. If one or none of the criteria was
present, symptoms were classified as non-specific.22
Definitions for hypertension, diabetes, dyslipidaemia, and
smoking differed slightly across hospitals (web appendix table
1). Table 1⇓ lists the most common definitions. We determined
coronary calcium scores by the Agatston method23 and used log
transformation to account for its skewed distribution.
Outcomes
Primary outcome was obstructive coronary artery disease,
defined as at least one vessel with at least 50% diameter stenosis
found on catheter based coronary angiography. Since we
combined existing databases from different hospitals, CT based
and catheter based coronary angiographies were performed at
each institution according to local protocols; we allowed both
visual assessment and quantitative assessment for the
interpretation of results for these procedures.
Statistical analysis
We assumed missing data occurred at random, depending on
the clinical variables and the results of CT based coronary
angiography, and performedmultiple imputations using chained
equations.24 Missing values were predicted on the basis of all
other predictors considered, the results of CT based coronary
angiography, as well as the outcome.25 26We created 20 datasets
with identical known information, but with differences in
imputed values reflecting the uncertainty associated with
imputations. In total, 667 (2%) clinical data items were imputed.
In our study, only a minority of patients underwent catheter
based coronary angiography. An analysis restricted to patients
who underwent catheter based coronary angiography could have
been influenced by verification bias.27 Therefore, we imputed
data for catheter based coronary angiography by using the CT
based procedure as an auxiliary variable, in addition to all other
predictors.28 Results for the two procedures correlate well
together, especially for negative results of CT based coronary
angiography.16-18 This strong correlation was confirmed in the
1609 patients who underwent both procedures (Pearson r=0.72).
Since its data were used for imputation, the CT based procedure
was not included as a predictor in the prediction models. Our
approach was similar to using the results of CT based coronary
angiography as the outcome variable when the catheter based
procedure was not performed (which was explored in a
sensitivity analysis). However, this approach is more
sophisticated because it also takes into account other predictors
and the uncertainty surrounding the imputed values.We imputed
3615 (64%) outcome values for catheter based coronary
angiography. Multiple imputations were performed using
Stata/SE 11 (StataCorp).
External validation of the Duke clinical score
To evaluate the performance of the Duke clinical score, we
calculated the predicted probability based on published
coefficients13 (that is, prediction of ≥75% stenosis). Since
patients with evidence of previous coronary artery disease were
excluded, we assumed all had a normal resting
electrocardiogram. If resting findings were available and taken
into account, any overestimation would increase further. We
used a calibration plot to compare predicted probability with
the observed proportions of severe disease (that is, ≥70%
stenosis or ≥50% left main stenosis) in a calibration plot.
Development of new prediction models
We defined three prediction models: a basic model including
age, sex, symptoms, and setting; a clinical model including age,
sex, symptoms, setting, diabetes, hypertension, dyslipidaemia,
smoking, and bodymass index; and an extendedmodel including
all clinical variables and the coronary calcium score. Since all
clinical variables are known to be associated with coronary
artery disease,29 all predictors were entered simultaneously in
a multivariable, random effects, logistic regression model. We
included hospital as a random effect to account for clustering
of patients within hospitals. Availability of data for exercise
electrocardiography was limited, and web appendix table 5
explores the variable’s incremental predictive value.We omitted
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non-significant predictors with small effects (that is, odds ratio
<1.01).
Setting variable
To account for differences in patient selection across datasets
(based on referrals to catheter based coronary angiography v
CT based coronary angiography), we created a dummy variable
for setting. This variable was coded “0” (low prevalence setting)
if a patient came from a database that was created by selecting
patients who underwent CT based coronary angiography (of
whom only a proportion underwent the catheter based procedure
in addition to the CT based procedure), and coded as “1” (high
prevalence setting) if a patient came from a database that was
created by selecting patients who underwent catheter based
coronary angiography (of whom a proportion also underwent
the CT based procedure).
We intended to apply our prediction models to patients in low
prevalence populations, for whom the best diagnostic
management should be determined based on an estimated pretest
probability.10 By contrast, all patients in the high prevalence
setting had a clinical indication for catheter based coronary
angiography, in whom estimating the pretest probability would
not be relevant to them. However, because it would be inefficient
to derive a prediction model in a low prevalence population
only (since most patients will not undergo the reference
standard), we also included databases with patients referred for
catheter based coronary angiography. These data provided
valuable information on the correlations between clinical
presentation, risk factors, and the two angiography procedures,
which was essential for reliable imputation of covariables and
outcomes in the low prevalence populations. By including the
setting variable, we could derive the model using all available
data, and adjust for differences in patient selection. When
applying the model for new patients with chest pain, the setting
variable was set to zero.
Predictor effects might differ across the low and high prevalence
settings, and we tested these differences by using interaction
terms between setting and all other variables. We also tested
interactions between symptoms and sex, symptoms and age,
and symptoms and diabetes. Linear effects of age and the log
transformed coronary calcium score were tested by including a
restricted cubic spline function with three knots (df=2).30 31
We quantified diagnostic performance by calculating the area
under the receiver operating characteristics curve (c statistic).
Reclassification was assessed by use of the continuous net
reclassification improvement (web appendix table 2).32 We
regarded P<0.05 to be statistically significant. Analyses were
performed using Stata/SE 11 (StataCorp).
Validation
We assessed the validity of the clinical model in a cross
validation procedure. The four largest low prevalence databases
with sufficient numbers for reliable validation,33 and the
remaining low prevalence databases combined, were each in
turn removed from the model development sample. We then
validated eachmodel using the database that was omitted during
model development. We calculated the c statistic and validated
the model according to the steps in the box (the web appendix
provides more detail).26 30 31
Results
Data collection and study population
We retrieved databases from 18 hospitals (table 1 and web
appendix table 2). The study population included 5677 patients
(3283 men, 2394 women; mean age 58 and 60 years,
respectively). Nearly all patients (5190, 91%) underwent CT
based coronary angiography, which revealed obstructive
coronary artery disease in 1634 (31%). Of these 1634 patients,
1083 (66%) underwent catheter based coronary angiography,
which showed positive results in 886 (82%). Of the 3556
patients without obstructive disease on CT based coronary
angiography, 526 (15%) underwent catheter based coronary
angiography, which showed negative results in 498 (95%).
Overall, 2062 (36%) patients underwent catheter based coronary
angiography, with 1176 (57%) diagnosed with obstructive
coronary artery disease. Missing values occurred in four (0.1%)
patients for age, six (0.1%) for symptoms, 126 (2.2%) for
hypertension, 189 (3.3%) for diabetes, 187 (3.3%) for
dyslipidaemia, 155 (2.7%) for smoking, 354 (6.2%) for body
mass index, and 810 (14%) for coronary calcium score.
Of the 3556 patients who did not have obstructive coronary
artery disease revealed by CT based coronary angiography,
3030 (85%) did not undergo the catheter based procedure.
Results for catheter based coronary angiography were imputed
for these patients, and were mostly negative (range 97-98.4%
across the multiple imputations), which accords with the high
negative predictive value of the CT based procedure. Of the
1634 patients who had obstructive disease revealed by the CT
based procedure, 551 (34%) did not undergo subsequent catheter
based coronary angiography. For these patients, results for the
catheter based procedure were imputed, and were mostly
positive (range 65-77% across imputations), which accords with
a reduced positive predictive value of the CT based procedure.
External validation of the Duke clinical score
External validation of the Duke clinical score overestimated the
probability of severe coronary artery disease, as observed in our
dataset (fig 1⇓ and web appendix table 3).
Development of new prediction models
Table 2⇓ summarises the results of the random effects analysis
in logistic regression and the continuous net reclassification
improvement (web appendix table 4 provides more detail). The
prediction models are available as an online probability
calculator (http://rcc.simpal.com/NpfpV5; web appendix fig
A2). In the clinical model, all predictors except bodymass index
were significantly associated with obstructive coronary artery
disease. The clinical model improved the prediction, compared
with the basic model (cross validated c statistic improved from
0.77 to 0.79; table 2). Whereas an abnormal exercise
electrocardiography had limited predictive value in the
multivariable prediction model (web appendix table 5), the
coronary calcium score was a major predictor, which increased
the c statistic from 0.79 to 0.88 (table 2). Most predictor effects
decreased after addition of the coronary calcium score;
dyslipidaemia and smoking were no longer significant. We
obtained similar results when using CT based coronary
angiography as the outcome in patients who did not undergo
catheter based coronary angiography.
Validation
Figure 2⇓ and web appendix table 6 show the cross validation
results for the clinical model. The c statistic ranged from 0.78
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Box: Cross validation procedure
Calibration-in-the-large
When assessing the validity of a prediction model, the first step is to check whether the average prediction approximates the average
observed outcome. This concept is referred to as “calibration-in-the-large”. In this study, we compared the mean observed frequency of
coronary artery disease in the validation data with the mean predicted probability. A negative value would imply that the mean observed
proportion in the validation data is lower than the mean predicted probability. Conversely, a positive value would indicate that the mean
observed proportion in the validation data was higher than the mean predicted probability. A statistically significant result indicates significant
miscalibration, whereas a non-significant result supports validity of the prediction model
Logistic recalibration
The second step is to test whether the overall effect of the predictors in the model is valid for the validation data. The overall predictor effects
in the validation data were re-estimated and compared with the reference overall predictor effects in the prediction model (reference is set
to zero). A negative value would imply that the overall effects of the predictors in the validation data were lower than those in the prediction
model. Conversely, a positive value would indicate that the overall effects of the predictors in the validation data were stronger than those
in the prediction model. A significant result would indicate significant miscalibration of the predictor effects, whereas a non-significant result
would indicate no difference in predictor effects, supporting the validity of the model
Re-estimation
The third step is to re-estimate the predictor effects in the validation data and calculate the difference (∂ coefficients) with the estimated
predictor effects in the prediction model (web appendix).26 Non-significant differences (high P values) indicate no difference in the predictor
effect, supporting the validity of the model
to 0.81. The continuous net reclassification improvement was
a measure of the relative change in the observed proportion
when the predicted probability changes (web appendix), which
was most favourable (102%) for the extended model compared
with the clinical model (table 2).
Assessment of calibration-in-the-large showed a significant
difference between the mean observed outcome and the
predicted probability (clinical model), for Azienda Ospedaliero
Universitaria Parma, Rotterdam, and the combined low
prevalence hospitals (fig 2). Logistic recalibration showed no
significant differences between the overall hospital specific
effects of the predictors compared with the overall effects of
the predictors in the clinical model (fig 2). When re-estimated
in specific datasets, the predictor effects were not significantly
different from the predictor effects in the clinical model, except
for the effect of typical chest pain for Azienda Ospedaliero
Universitaria Parma. The results indicated that predictor effects
were similar across datasets (web appendix table 6).
Discussion
Summary of key findings
With recently collected data and modern statistical methods,
we developed a prediction model that performed well in
estimating the probability of coronary artery disease. The need
for an updated model was evident by our results showing that
the Duke clinical score significantly overestimated the
probability of coronary artery disease. Age, sex, symptoms, and
coronary calcium score were strong predictors for disease. The
clinical model predicted probabilities between 2% for a 50 year
old womanwith non-specific chest pain without any risk factors,
and 91% for an 80 year old man with typical chest pain and
multiple risk factors.
Previous publications
In 1979, Diamond and Forrester11 showed the importance of
age, sex, and symptoms in the prediction of coronary artery
disease. Despite its limitations, current guidelines still
recommend the use of Diamond and Forrester’s model.7 8 As
previously shown, the model tends to overestimate the
probability of coronary artery disease, mainly in women,14 and
does not take into account cardiovascular risk factors associated
with the presence of the disease.
In 1993, Pryor and colleagues12 13 developed the Duke clinical
score in a large cohort of patients who underwent catheter based
coronary angiography. The model predicted the presence of at
least 75% stenosis, on the basis of age, sex, symptoms, history
of myocardial infarction, smoking, dyslipidaemia, diabetes, and
resting electrocardiography findings. In our study, we showed
that the Duke clinical score also overestimated the probability
of coronary artery disease.
Limitations of the study
The study population was derived from existing databases, some
of which were designed for other research objectives (such as
to investigate the diagnostic accuracy of CT based coronary
angiography for coronary artery disease). In some studies, all
patients underwent the reference standard test, whereas other
studies selected patients for catheter based coronary angiography
on the basis of results from the CT based procedure. When
evaluating the diagnostic performance of CT based coronary
angiography, selection on the basis of the test results could lead
to verification bias or selective referral bias, which could affect
the sensitivity and specificity estimates of such a test. However,
in the current study, we did not assess the diagnostic value of
the CT based procedure, thus making bias less likely. We also
considered patients who underwent the CT based procedure
only and not the catheter based procedure. We selected patients
who underwent either angiography, or both procedures.
However, not all patients presenting with chest pain will be
referred for one procedure or the other, which limits the
generalisability of our results.
To also consider patients who did not undergo catheter based
coronary angiography, we multiply imputed these results on the
basis of results from the CT based procedure and all other
covariables. Although data for the catheter based procedure
were imputed for a large proportion of patients, we believe that
the high sensitivity and specificity of the CT based procedure
justifies the imputation; we also did not consider the CT based
procedure as an explanatory variable in the prediction models.
However, the CT based procedure could overestimate the
severity of disease, which in turn could have overestimated the
imputed severity of disease from the catheter based procedure.
If bias was present in our models, it would tend to advocate
further diagnostic investigation rather thanmissing the diagnosis.
We combined existing data from several different hospitals.
Since the current analysis was not the main purpose of the data
collection, the selection of patients, availability of data, and
predictor definitions differed across hospitals (web appendix
table 1). Furthermore, some hospitals used quantitative coronary
angiography to determine the degree of stenosis, whereas others
used visual assessment. Overall, heterogeneity due to differences
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between protocols, level of physician experience, and guideline
adherence across hospitals could have influenced our results.
Despite these limitations, the models presented had generally
good discrimination (via the c statistic) and calibration.
Because we intended to use our model in low prevalence
populations, cross validation was performed using only the low
prevalence datasets. The cross validation results in the data from
Parma, Rotterdam, and the smaller hospitals combined, were
less favourable in terms of calibration-in-the-large, possibly
explained by heterogeneity. However, in general, calibration
assessed graphically (fig 2) could be considered satisfactory,
suggesting that the model is generalisable to other settings.
Further external validation of our model in other populations is
still needed.
Our study focused on the prediction of obstructive coronary
artery disease according to age, sex, type of chest pain,
cardiovascular risk factors, setting, and coronary calcium score.
Unfortunately, no data were available to assess the predictive
value of findings based on other imaging tests (such as nuclear
perfusion imaging, perfusion magnetic resonance imaging, and
echocardiography). Furthermore, we were unable to show
incremental predictive value of exercise electrocardiography,
which may be explained by the limited availability of data.
Finally, our analysis focused on the diagnostic prediction of the
presence of coronary artery disease, defined as at least 50%
diameter stenosis in at least one vessel, shown on catheter based
coronary angiography. Predicting severe disease (for example,
≥70% stenosis in the left anterior descending coronary artery,
three vessel disease, or left main coronary artery disease) would
be helpful as a tool to select patients for revascularisation.
However, the main purpose of the current analysis was the
development of prediction models to help physicians select
patients who would benefit from further testing.
Future directions
Other non-invasive imaging tests for the evaluation of patients
with chest pain should also be considered as predictors for the
presence of coronary artery disease. Furthermore, cost
effectiveness analyses should be performed to establish
appropriate thresholds for diagnostic testing, taking into account
the long term benefits and harms.4 34
Clinical implications
We showed that the Duke clinical score overestimates the
likelihood of coronary artery disease, and we believe that our
model improves the estimate of the pretest probability. By
contrast with the Duke clinical score, we developed and
validated our model using data from different hospitals, settings,
countries, and included hypertension as a predictor. Finally, our
model does not need inclusion of resting electrocardiography
findings, which could be convenient in primary practice.
A refined estimate of the probability of coronary artery disease
allows doctors to make better decisions as to which diagnostic
test is best in a particular patient, according to NICE guidelines,
and to decide on further management based on the results of
such tests. Our stepwise models can be used to evaluate the
added value of performing coronary calcium score either before
performing the test or after obtaining the calcium score. Our
analysis shows that the coronary calcium score significantly
improves the estimate of the probability of coronary artery
disease, suggesting that the score should be considered for
patients with chest pain. Use of the coronary calcium score is
not routinely recommended by the guidelines from theAmerican
College of Cardiology/American Heart Association35 or the
European Society of Cardiology,9 whereas the UK guidelines
recommend use of the score if the pretest probability is
10-29%.10However, triage strategies using the coronary calcium
score have been proposed35 and are implemented in several
centres. In this context, our prediction calculator could be used
both to determine whether using the coronary calcium score is
clinically useful (by checking whether the score alters the
probability of coronary artery disease such that clinical
management would change) and to determine the revised
probability of coronary artery disease, based on the score’s
result.
Our findings also suggest that the diagnostic value of exercise
electrocardiography is limited (web appendix), which accords
with its low sensitivity and specificity for detecting coronary
artery disease,36 and with explicit recommendations in the UK
not to use the test to diagnose or exclude disease in patients
with chest pain.10 However, many physicians argue that the
prognostic information obtained by exercise electrocardiography
remains important for clinical practice. Alternatively, coronary
calcium scores provide both diagnostic37-39 and prognostic
information.40-43
Prediction tools are useful only when they are easily accessible
at the point of care, which is why we designed an online
calculator (web appendix fig A2). The calculator could be
implemented in electronic patient records, electronic order entry
systems, or smartphone or tablet applications. Overall, prediction
models that include age, sex, symptoms, and risk factors allow
for accurate estimation of the probability of coronary artery
disease in low prevalence populations. The addition of using
the coronary calcium score improved the prediction of the
disease. Implementation of these models could improve clinical
outcomes, but would need further evaluation.
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What is already known on this topic
Current guidelines recommend use of the Diamond and Forrester model or Duke clinical score to estimate the pretest probability of
coronary artery disease in patients presenting with stable chest pain
The pretest probability of disease helps physicians identify which patients are most likely to benefit from further testing
What this study adds
The Duke clinical score overestimates the probability of coronary artery disease
An updated prediction model for low prevalence populations was developed and validated using individual patient data from 18 different
hospitals
Use of the CT based coronary calcium score in the updated model improved the predicted probability of disease
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Tables
Table 1| Patient characteristics. Most commonly used risk factor definitions provided; characteristics data are no (%) of patients unless
stated otherwise
High prevalence setting (8 hospitals)Low prevalence setting (10 hospitals)
Characteristic
No (%) of patients with
available dataValue
No (%) of patients with
available dataValue
No of patients per hospital
1251 (100)156 (85-549)4426 (100)443 (80-1241)Mean (range)
Age (years)
1251 (100)63.6 (10)4422 (99.9)57.2 (12)Mean (standard deviation)
57-7049-66Interquartile range
18-9318-92Range
Sex
1251 (100)877 (46)4426 (100)2406 (54)Male
Chest pain*
1247 (99.7)656 (53)4424 (99.9)759 (17)Typical
278 (22)2699 (61)Atypical
313 (25)966 (22)Non-specific
Other clinical characteristics
1250 (99.9)229 (18)4238 (96)622 (15)Diabetes†
1251 (100)840 (67)4300 (97)2475 (58)Hypertension‡
1235 (99)801 (65)4255 (96)2194 (52)Dyslipidaemia§
1249 (99.8)454 (36)4273 (97)1231 (29)Smoking¶
1206 (96)28 (27)4117 (93)28 (27)Body mass index (mean
(median))**
History
265 (21)136 (51)3938 (89)1720 (44)Family history of coronary artery
disease††
269 (22)25 (9)2531 (57)78 (3)Previous cerebrovascular
disease‡‡
316 (25)2 (1)3351 (76)43 (1)Previous renal artery disease
369 (29)10 (3)3356 (76)79 (2)Previous peripheral arterial
disease
Exercise electrocardiography
547 (44)166 (30)1612 (36)671 (42)Normal
336 (61)443 (27)Abnormal
45 (8)498 (31)Non-diagnostic
Coronary calcium score§§
858 (69)442 (643), 1824009 (91)160 (399), 4Mean (standard deviation),
median
155 (18)1777 (44)0
44 (5)402 (10)0-<10
154 (18)749 (19)10-<100
208 (24)606 (15)100-<400
297 (35)475 (12)≥400
Results from CT based coronary angiography¶¶
903 (72)324 (36)4287 (97)3232 (75)No obstructive CAD
501 (55)505 (12)Moderate CAD
78 (9)550 (13)Severe CAD
Results from catheter based coronary angiography***
1214 (97)480 (40)848 (19)406 (48)No obstructive CAD
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Table 1 (continued)
High prevalence setting (8 hospitals)Low prevalence setting (10 hospitals)
Characteristic
No (%) of patients with
available dataValue
No (%) of patients with
available dataValue
541 (45)177 (21)Moderate CAD
193 (16)265 (31)Severe CAD
Patients who underwent both CT based coronary angiography and catheter based coronary angiography
Results from CT based coronary angiography¶¶
867 (69)296 (34)742 (17)230 (31)No obstructive CAD
495 (57)277 (37)Moderate CAD
76 (9)235 (32)Severe CAD
Results from catheter based coronary angiography***
867 (69)339 (39)742 (17)356 (48)No obstructive CAD
436 (50)172 (23)Moderate CAD
92 (11)214 (29)Severe CAD
CAD=coronary artery disease; moderate CAD=50-70% stenosis; severe CAD=≥70% stenosis or ≥50% left main stenosis.
*According to traditional chest pain classification.19
†Defined as fasting glucose levels of ≥7 mmol/L or treatment with diet intervention, oral glucose lowering agent, or insulin.
‡Defined as blood pressure of ≥140/90 mm Hg or the use of antihypertensive drugs.
§Defined as total cholesterol concentration of ≥5.2 mmol/L or treatment with lipid lowering drugs.
¶Includes current or past smoking.
**Defined as weight (kg) divided by height (m2).
††Presence of CAD in a first degree female relative (age <65 years) or male relative (age <55 years).
‡‡History of carotid artery disease, stroke, or transient ischaemic attack.
§§Agatston score as measured by computed tomography.20
¶¶Some hospitals only compared obstructive CAD (≥50% stenosis) with no obstructive CAD (hospital numbers 2, 3, and 18 in web appendix table 1; for example,
they did not consider the severe category for coronary computed tomography angiography). One hospital did not categorise patients with ≥50% left main stenosis
in the severe CAD category (hospital number 6 in web appendix table 1).
***Two hospitals only compared obstructive CAD (≥50% stenosis) with no obstructive CAD (hospital numbers 2 and 18 in web appendix table 1; for example, they
did not consider the severe category for catheter based coronary angiography).
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Table 2| Random effects logistic regression analysis* and cross validation, in the low prevalence setting
Prediction model
ExtendedClinicalBasic
1.11 (0.99 to 1.25)1.85 (1.70 to 2.02)1.89 (1.74 to 2.04)Age (per 10 years)
2.19 (1.75 to 2.75)3.79 (3.13 to 4.58)3.89 (3.24 to 4.66)Male sex
Chest pain (v non-specific chest pain)
2.05 (1.50 to 2.80)1.88 (1.44 to 2.46)1.93 (1.48 to 2.52)Atypical
7.57 (5.56 to 10.3)7.36 (5.64 to 9.61)7.21 (5.64 to 9.22)†Typical, if diabetes is absent
3.46 (2.12 to 5.63)4.91 (3.16 to 7.63)—Typical, if diabetes is present
1.93 (1.41 to 2.65)2.29 (1.72 to 3.04)—Diabetes
1.26 (1.04 to 1.54)1.40 (1.18 to 1.67)—Hypertension
1.20 (0.95 to 1.53)1.53 (1.25 to 1.86)—Dyslipidaemia
1.23 (0.97 to 1.55)1.59 (1.30 to 1.93)—Smoking
Coronary calcium score
4.69 (3.76 to 5.84)——Log transformed (per standard deviation)
2.23 (1.34 to 3.74)——0-<10‡
5.04 (3.38 to 7.52)——≥10-<100‡
15.3 (9.96 to 23.5)——≥100-<400‡
35.9 (22.6 to 56.9)——≥400‡
Cross validation (mean§)
0.880.790.77C statistic
10235—Net reclassification improvement (%)¶
Data are odds ratio (95% confidence interval) unless stated otherwise. All odds ratios showed significant associations (P<0.05) apart from age, dyslipidaemia, and
smoking in the extended model.
*Random effect for hospital included to account for clustering of patients within hospitals. Body mass index omitted from all analyses because odds ratio was less
than 1.01 and was non-significant. Setting and the interaction between diabetes and typical chest pain, and between setting and coronary calcium score were
predictive and were included in all models. All other interactions were not significant. Test for a non-linear effect of age was not significant. Evidence indicated
additional non-linear effect of coronary calcium score beyond the log transformation, which was considered not clinically important, and omitted for simplicity.
†Irrespective of diabetic status, since basic model does not include diabetes.
‡Separate analysis using coronary calcium score as a categorical variable, adjusted for all other predictors in the model, reference category is score 0.
§Mean of the cross validation procedures calculated using the four largest low prevalence datasets and remaining low prevalence datasets combined.
¶Calculated by comparison with the next model on the left; defined as weighted sum of the increase in observed proportion among patients whose predicted
probability goes up, and decrease in observed proportion among those whose predicted probability goes down (web appendix).29
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Figures
Fig 1 Calibration plot of the Duke clinical score, in low prevalence datasets (n=4426). Distribution of predicted probabilities
shown separately for patients with and without severe coronary artery disease. Triangles indicate observed proportions of
severe disease, by tenths of predicted probability; 95% CI=confidence interval
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Fig 2 Validity of clinical model using the four largest low prevalence datasets and the smaller remaining low prevalence
databases combined. Distribution of predicted probabilities shown separately for patients with and without obstructive
coronary artery disease. Triangles indicate observed proportion of disease, by tenths of the predicted probability; 95%
CI=95% confidence interval
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